Resource

 

 

 

 

 

 

 

 

 

 

 

Slaughter and May advised on SoftBank Vision Fund’s investments in Ping An Good Doctor and Ping An Healthcare Technology

15 Feb 2018

Slaughter and May advised SB Investment Advisers (UK) Limited (SBIA), an investment adviser to SoftBank Vision Fund, on SoftBank Vision Fund’s investment in two technology companies in the Ping An group - Ping An Healthcare and Technology Company Limited (Ping An Good Doctor) and Ping An Medical and Healthcare Management Co., Ltd. (Ping An Healthcare Technology).

Heuking Kühn Lüer Wojtek advises DATAGROUP SE on acquisition of almato GmbH

15 Feb 2018

Heuking Kühn Lüer Wojtek comprehensively advised DATAGROUP SE on the acquisition of all shares in Reutlingen-based almato GmbH and accompanied the transaction.
 
Almato GmbH, founded in 2002, specializes in optimizing standard business processes and is one of the pioneers in the field of full and partial automation.
 
DATAGROUP SE, headquartered in Pliezhausen, is a leading German IT service company with more than 1,900 employees.
 

Jeantet advise on the acquisition of Cheerz by CEWE Stiftung & Co. KGaA

15 Feb 2018

CEWE Stiftung & Co. KGaA, Oldenburg, acquired approx. 80% of the shares of Stardust Media And Communication S.A.S., Paris, from its founders and financial investors and secured the acquisition of the remaining approx. 20% of the shares by way of options.

With its brand “Cheerz”, primarily targeted at smartphone users, the company is very successful in France, Spain and Italy and is growing dynamically.

Jeantet advised CEWE comprehensively with the following team:

– Karl Hepp de Sevelinges (Partner, Lead M&A, Paris)

DLA Piper advises ASB Capital in sale of Infomart Data Centers' Dallas operations

15 Feb 2018

DLA Piper represented ASB Capital Management LLC in the sale of Infomart Data Centers' Dallas operations to Equinix, Inc. for US$800 million. The acquired assets include the Infomart Dallas building, the iconic carrier hotel that serves as the primary interconnection hub for networks in the Southern United States.

The transaction is expected to close during the first half of 2018.

Schulte Advises Sustainable Growth Advisers in Acquisition by Virtus Investment Partners Inc.

15 Feb 2018

Schulte advised Sustainable Growth Advisers (SGA), an employee-owned investment manager, in its sale of a majority stake to Virtus Investment Partners Inc., which operates as a multi-manager asset management business. SGA has $11.6 billion in assets under management in U.S. and international growth equity strategies. The transaction, in which Virtus will purchase interest held by private equity firm Estancia Capital Management and by SGA's partners, will expand Virtus' investment offerings and diversify and expand its clients base.

Schulte Advises Veritas Capital and its Affiliates in Acquisition of PricewaterhouseCoopers' US Public Sector Business

15 Feb 2018

Schulte represented Veritas Capital and its affiliates in their acquisition of the U.S. public sector business of PricewaterhouseCoopers LLP.  PwC’s U.S. public sector business helps governments — federal, state and local — and multilateral agencies solve complex business problems, improve processes and manage risk through its capabilities in financial management, strategy development, program management, operational effectiveness and organization design.

Kirkland Advises Wyndham Worldwide on Sale of European Vacation Rentals Business

15 Feb 2018

Kirkland & Ellis advised Wyndham Worldwide Corporation (NYSE: WYN), one of the largest global hospitality companies, on its agreement to sell its European vacation rental business to Platinum Equity for approximately US$1.3 billion. Wyndham’s European business offers access to more than 45,000 properties through over 20 brands including Hoseasons, cottages.com, James Villa Holidays, Landal GreenParks and Novasol, making it the largest manager of holiday rentals in Europe.

Ropes & Gray Advises Harbin Pharmaceutical in a $300 Million Strategic Investment and China Joint Venture with GNC Holdings, Inc.

15 Feb 2018

Ropes & Gray is advising Harbin Pharmaceutical Group Holding Co., Ltd, a leading pharmaceutical company in China, in a strategic investment of approximately $300 million in GNC Holdings, Inc. Upon closing, it will become the single largest shareholder in GNC.

In addition, GNC and Harbin Pharmaceutical have agreed to form a joint venture for the manufacturing, marketing, sale and distribution of GNC-branded products in China. The transaction is expected to close in the second half of 2018, subject to customary closing conditions.